{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T13:12:45Z","timestamp":1784380365464,"version":"3.55.0"},"reference-count":24,"publisher":"Informa UK Limited","issue":"23","funder":[{"name":"Center for AIDS Research","award":["NIH (AI027763)"],"award-info":[{"award-number":["NIH (AI027763)"]}]},{"name":"Center for AIDS Research","award":["R01 (HD068174)"],"award-info":[{"award-number":["R01 (HD068174)"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.4155\/bio.14.254","type":"journal-article","created":{"date-parts":[[2014,12,22]],"date-time":"2014-12-22T13:21:32Z","timestamp":1419254492000},"page":"3081-3089","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":32,"title":["Determination of The Antimalarial Drug Piperaquine in Small Volume Pediatric Plasma Samples by LC\u2013MS\/MS"],"prefix":"10.1080","volume":"6","author":[{"given":"Linda L","family":"Kjellin","sequence":"first","affiliation":[{"name":"Drug Research Unit, Department of Clinical Pharmacy, University of California at San Francisco, San Francisco, CA94143, USA"},{"name":"Division of Pharmacokinetics & Drug Therapy, Department of Pharmaceutical Biosciences, Uppsala University, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Dorsey","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California at San Francisco, San Francisco, CA94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California at San Francisco, San Francisco, CA94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Aweeka","sequence":"additional","affiliation":[{"name":"Drug Research Unit, Department of Clinical Pharmacy, University of California at San Francisco, San Francisco, CA94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liusheng","family":"Huang","sequence":"additional","affiliation":[{"name":"Drug Research Unit, Department of Clinical Pharmacy, University of California at San Francisco, San Francisco, CA94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,12,22]]},"reference":[{"key":"e_1_3_4_3_1","unstructured":"World Health Organization . Guidelines for the Treatment of Malaria (2nd Edition)March 2010. http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241547925_eng.pdf."},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013438"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001689"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084976"},{"key":"e_1_3_4_7_1","first-page":"CD010927","article-title":"Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria","volume":"1","author":"Zani B","year":"2014","unstructured":"Zani B , GathuM, DoneganS, OlliaroPL, SinclairD. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria. Cochrane database Sys. Rev. 1, CD010927 (2014).","journal-title":"Cochrane database Sys. Rev"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.10-0158"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565010-00004"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2007.12.011"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/41.1.44"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1570-0232(03)00209-5"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2005.03.031"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2007.09.021"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2009.02.006"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.4459"},{"key":"e_1_3_4_17_1","unstructured":"Clinical Pharmacology Quality Assurance (CPQA) Program : CPQA guidelines for chromatographic method development and validation based on (and including) FDA guidelines dated May 2001. Version 4.0. (2012). www.fstrf.org."},{"key":"e_1_3_4_18_1","unstructured":"Food and Drug Administration . Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services Washington DC USA (2001). www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm070107.pdfCenter."},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac020361s"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2012.693972"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05877-11"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit078"},{"key":"e_1_3_4_23_1","unstructured":"European Medicine Agency . Guideline on Bioanalytical Method Validation. Committee for Human Medicinal Products London UK (2011)."},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.11.303"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200501"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-010-0804-7"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/bio.14.254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T11:33:40Z","timestamp":1715945620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/bio.14.254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":24,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.4155\/bio.14.254"],"URL":"https:\/\/doi.org\/10.4155\/bio.14.254","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-12-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}